drugset / Trial / NCT01450124
Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)
NaSingle-groupOpen-labelTreatment
Summary
To determine the safety and tolerability of BOSWELAN in subjects with multiple sclerosis or clinically isolated syndrome and to describe the effect of Boswellic acids on the disease activity as assessed by monthly MRI measures.
Timeline
- Start
- 2011-09
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Boswellic acids | Unknown | 400 mg | Oral |
| Subject | Boswellic acids | Unknown | 1600 mg | Oral |